Early P2Y12 Inhibitor Single Antiplatelet Therapy for High-Bleeding Risk Patients After Stenting - PENDULUM Mono 24-Month Analysis.
Nakagawa Y, Kadota K, Nakao K, Shite J, Yokoi H, Kozuma K, Tanabe K, Akasaka T, Shinke T, Ueno T, Hirayama A, Uemura S, Iijima R, Harada A, Kuroda T, Takita A, Murakami Y, Saito S, Nakamura M.
Nakagawa Y, et al. Among authors: kuroda t.
Circ J. 2022 Aug 25;86(9):1352-1361. doi: 10.1253/circj.CJ-21-1004. Epub 2022 May 17.
Circ J. 2022.
PMID: 35584932
Free article.
BACKGROUND: In PENDULUM mono, Japanese patients with high bleeding risk (HBR) received short-term dual antiplatelet therapy (DAPT) followed by single antiplatelet therapy (SAPT) with prasugrel after percutaneous coronary intervention (PCI). ...CONCLUSIONS: Japanese PCI pat …
BACKGROUND: In PENDULUM mono, Japanese patients with high bleeding risk (HBR) received short-term dual antiplatelet therapy (DAPT) fo …